Sign up online today & collaborate
or click here to find out more
Patients with psoriatic arthritis have been granted access to Janssen’s biologic therapy Stelara on the National Health Service in England and Wales.
The National Institute for Health and Care Excellence has confirmed reimbursement for the drug in new technology appraisal guidance endorsing the treatment for certain patients, marking a u-turn from an earlier decision to bar its routine use.For more click here
Source: Pharma times